首页>
外文期刊>Journal for ImmunoTherapy of Cancer
>Correction: Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
【24h】
Correction: Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
Since the online publication of this article, the authors have noticed errors in Table 1 and 2. In Table 1, the header 'Approved immunocompromised patients (n=33)' should read 'Approved immunocompromised patients (n=37)' as the total number of patients is 37. Additionally in Table 2 row ‘CR’, column ‘1L (n=15)’, the data value is incorrectly stated as ‘5 (33.3)2 (13.3)’. The correct data value is ‘2 (13.3)’.
展开▼